Enzyme-Engineered Conjugated Polymer Nanoplatform for Activatable Companion Diagnostics and Multistage Augmented Synergistic Therapy

© 2022 Wiley-VCH GmbH.

Bibliographische Detailangaben
Veröffentlicht in:Advanced materials (Deerfield Beach, Fla.). - 1998. - 34(2022), 18 vom: 02. Mai, Seite e2200062
1. Verfasser: Wu, Jiayingzi (VerfasserIn)
Weitere Verfasser: Zhang, Yafei, Jiang, Kejia, Wang, Xiaoyu, Blum, Nicholas Thomas, Zhang, Jing, Jiang, Shanshan, Lin, Jing, Huang, Peng
Format: Online-Aufsatz
Sprache:English
Veröffentlicht: 2022
Zugriff auf das übergeordnete Werk:Advanced materials (Deerfield Beach, Fla.)
Schlagworte:Journal Article companion diagnostics glucose oxidase pH-responsive polyaniline synergistic therapy Polymers Glucose Oxidase EC 1.1.3.4
LEADER 01000naa a22002652 4500
001 NLM337748993
003 DE-627
005 20231225235123.0
007 cr uuu---uuuuu
008 231225s2022 xx |||||o 00| ||eng c
024 7 |a 10.1002/adma.202200062  |2 doi 
028 5 2 |a pubmed24n1125.xml 
035 |a (DE-627)NLM337748993 
035 |a (NLM)35243699 
040 |a DE-627  |b ger  |c DE-627  |e rakwb 
041 |a eng 
100 1 |a Wu, Jiayingzi  |e verfasserin  |4 aut 
245 1 0 |a Enzyme-Engineered Conjugated Polymer Nanoplatform for Activatable Companion Diagnostics and Multistage Augmented Synergistic Therapy 
264 1 |c 2022 
336 |a Text  |b txt  |2 rdacontent 
337 |a ƒaComputermedien  |b c  |2 rdamedia 
338 |a ƒa Online-Ressource  |b cr  |2 rdacarrier 
500 |a Date Completed 09.05.2022 
500 |a Date Revised 09.05.2022 
500 |a published: Print-Electronic 
500 |a Citation Status MEDLINE 
520 |a © 2022 Wiley-VCH GmbH. 
520 |a Companion diagnostics (CDx) provides critical information for precision medicine. However, current CDx is mostly limited to in vitro tests, which cannot accurately evaluate the disease progression and treatment response in real time. To overcome this challenge, herein a glucose oxidase (GOx)-engineered conjugated polymer (polyaniline, PANI) nanoplatform (denoted as PANITG) is reported for activatable imaging-based CDx and multistage augmented photothermal/starvation synergistic therapy. PANITG comprises a pH-activatable conjugated polymer as a photothermal convertor and photoacoustic (PA) emitter, a GOx as a cancer starvation inducer as well as a H2 O2 and acid producer, and a H2 O2 -cleavable linker as a "switch" for GOx activity. The in vivo PA imaging and photothermal therapy abilities are activated by acidic tumor microenvironment and self-augmented by the reaction between GOx and glucose. Meanwhile, the photothermal effect will enhance the GOx activity in turn. Such multistage augmentation of the therapeutic effects will facilitate effective cancer management. In addition, the in vivo PA imaging with PANITG reveals the tumor pH level which is correlated to the efficiency of the photothermal therapy and to the catalytic activity of GOx at each stage, enabling real-time activatable CDx 
650 4 |a Journal Article 
650 4 |a companion diagnostics 
650 4 |a glucose oxidase 
650 4 |a pH-responsive 
650 4 |a polyaniline 
650 4 |a synergistic therapy 
650 7 |a Polymers  |2 NLM 
650 7 |a Glucose Oxidase  |2 NLM 
650 7 |a EC 1.1.3.4  |2 NLM 
700 1 |a Zhang, Yafei  |e verfasserin  |4 aut 
700 1 |a Jiang, Kejia  |e verfasserin  |4 aut 
700 1 |a Wang, Xiaoyu  |e verfasserin  |4 aut 
700 1 |a Blum, Nicholas Thomas  |e verfasserin  |4 aut 
700 1 |a Zhang, Jing  |e verfasserin  |4 aut 
700 1 |a Jiang, Shanshan  |e verfasserin  |4 aut 
700 1 |a Lin, Jing  |e verfasserin  |4 aut 
700 1 |a Huang, Peng  |e verfasserin  |4 aut 
773 0 8 |i Enthalten in  |t Advanced materials (Deerfield Beach, Fla.)  |d 1998  |g 34(2022), 18 vom: 02. Mai, Seite e2200062  |w (DE-627)NLM098206397  |x 1521-4095  |7 nnns 
773 1 8 |g volume:34  |g year:2022  |g number:18  |g day:02  |g month:05  |g pages:e2200062 
856 4 0 |u http://dx.doi.org/10.1002/adma.202200062  |3 Volltext 
912 |a GBV_USEFLAG_A 
912 |a SYSFLAG_A 
912 |a GBV_NLM 
912 |a GBV_ILN_350 
951 |a AR 
952 |d 34  |j 2022  |e 18  |b 02  |c 05  |h e2200062